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Mergers and acquisitions involving various types of healthcare organizations have
been well documented in recent years and a number of published studies have evaluated
the pros and cons of these transactions. However, while increased consolidation activity
within the blood industry has been observed nationally, there are no published studies
that have empirically analyzed the impact of this activity. Due to the number of finalized
transactions during the past two decades, this study focuses on blood center consolidation
in Florida and explores the driving forces behind such activity. By employing a blended
qualitative and quantitative approach, a better understanding of the impact of blood
center consolidation was realized as it relates to key financial and operational indicators.
Findings suggest that there were several inherent benefits arising from consolidation,
although the results could not be generalized beyond the scope of the limited sample size.
The study did, however, provide insight into an empirical methodology that could be
used to evaluate future blood center consolidation activity.
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· CHAPTER I
INTRODUCTION
Background and Need

The United States healthcare system is in the midst of significant consolidation.
While much of the focus is on the consolidation that is occurring among healthcare
providers, the same marketplace trends have been observed among agencies and
organizations that are influenced by, or have direct dealings with hospitals and other
providers of healthcare services. Furthermore, while much of the recent consolidation
activity may be a function of industry realignment in anticipation of healthcare reform,
there is sufficient evidence to describe the historical forces driving consolidation, as well
as assess the impact of such activity on the broader healthcare industry (Bazzoli, Dynan,
Burns, & Yap, 2004).
Industry experts have predicted that the recently-adopted healthcare reform
legislation, while addressing issues related to access to healthcare services, will also serve
as an additional catalyst to an already growing trend of healthcare mergers and
acquisitions (Evans, 2010). According to various prognosticators, fewer hospitals will be
able to operate alone as a result of the changes that will occur in the healthcare insurance
and healthcare service delivery sectors (Minich-Pourshadi, 2010). As forecasted by the
key bond-rating agencies,_ this may also be true regarding

CJ.

variety of other healthcare-

related organizations (Evans, 2010; Spielman, 2010; Sheehan, 2011).
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Merger and acquisition activity among healthcare organizations in the 1990s created
a heightened awareness of the causes and effects of consolidation. Between 1995 and
2010, there were over 1,350 hospitals and health system transactions (Grauman, Harris,
& Martin, 2010). While this number includes both for-profit and not-for-profit

organizations, it clearly indicates that hospital consolidation has been among the most
active areas of the healthcare industry for the past several years.
The reasons for such activity are varied. Most revolve around financial challenges
facing independent hospitals, but there are also issues related to market dynamics,
consolidation of clinical services, and competitive pressures. The highest level of
consolidation occurred during the 1990s, tapering off somewhat between 2000 and 2009.
Nevertheless, with impending uncertainty related to healthcare reform and third-party
reimbursement, the level of merger activity will be on the rise once again (Tocknell,
2012).

Blueprint for the Future
With the enactment of The Patient Protection and Affordable Care Act (P.L. 111148) and The Health Care and Education Affordability Reconciliation Act of 20 10 (P .L.
111-152) in March, 2010, it is widely speculated that the United States healthcare
delivery system will undergo radical change. Together, these two pieces of legislation
comprise what is commonly referred to as "healthcare reform" and as a result of that
legislation the Congressional Budget Office estimates the expansion of healthcare
coverage to 32 million people at a cost of $940 billion over the subsequent ten year
period (Elmendorf, 2010). Once implemented, this legislation is expected to have longlasting effects on the entire healthcare industry.
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The uncertainty of the implications of this legislation has created a renewed sense
of urgency among healthcare providers, and has prompted even more speculation as to
the impact all healthcare-related organizations may expect (Evans, 2010). Further change
is on the horizon and all organizations within the broader healthcare industry must be
prepared to adapt accordingly.
Implications for Blood Centers
United States blood centers function in a relatively small niche industry within the
much broader healthcare delivery system. Blood centers serve as vendors to hospitals;
thus, their success or failure largely depends on the fluctuations of the hospital industry.
Therefore, it is important for blood centers to have a keen awareness of the issues facing
hospitals, and to evaluate the impact these issues will have on the blood industry.
During the past three decades, there have been over thirty documented mergers andlor
acquisitions involving United States blood centers, reducing the total number of
independent centers from just over 100 to 75 (MacPherson. 2010). The driving forces
behind this consolidation activity are very similar to those that have led to consolidation
among hospitals: financial viability, operating efficiency, economies of scale, and market
power (Harrison, 2006; Zuckerman, 2011). Many blood centers fear that their very
survival may be in jeopardy if they remain independent, without the enhanced support
and resources of a larger organization. The consolidation activity to date includes blood
centers of all sizes, but generally larger centers acquire smaller centers or mergers of
equal size may occur (Fuchs, 2011). It is forecasted that this trend will accelerate as a
result of healthcare reform.
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Problem Statement
Consolidation within the healthcare industry is not a new phenomenon. Hospitals and
other healthcare organizations have been involved in merger and acquisition activity for
several decades, and there have been numerous published studies that evaluate and
analyze their success or failure (Bazzoli, Dynan, Burns, & Yap, 2004). However, while
increased consolidation activity within the blood industry has been observed nationally,
there are no published studies that empirically analyze the impact of this activity. If the
rate of mergers and acquisitions within the blood industry continue to accelerate as
forecasted, it would be beneficial to the industry to have an objective basis upon which to
evaluate the predictors of consolidation activity.

Research Question
A presumed benefit of a merger or acquisition involving two or more blood centers is
that the result will lead to enhanced benefits for the new entity . Yet, this mayor may not
be the case when the transaction is evaluated on well-defined criteria that are applied both
pre- and post-consolidation. The aim of this study is to conduct a critical analysis of the
impact of blood center consolidation activity in Florida between 1991 and 2011.
Financial and operational measures will be evaluated to determine the impact of
consolidation with respect to financial performance and operational efficiencies.

Population
The United States blood industry is composed of three primary sectors. The
American Red Cross (ARC) operates regional donor centers which are located across
many parts of the country. Approximately 40% of the United States blood supply is
collected by the ARC (American Red Cross, 2012). A second major sector of the blood
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industry is composed of approximately 75 independent blood centers which collect and
process approximately 50% of the nation's blood supply (America'S Blood Centers,
2011). The remaining 10% is collected by the military or in a relatively small number of
hospital-based collection centers (DHHS, 2009). Collectively, the three sectors represent
approximately $5 billion in annual sales and 16 million annual blood donations.
In the state of Florida alone, consolidation activity among blood centers has been
significant. In 1991, there were 20 Florida blood centers, each operating independently.
By 2011, there were only seven independent blood centers, a direct result of mergers or
acquisitions during that time (AABB, 2011).
This study focuses on blood center consolidation activity in Florida during the 20year period from 1991 - 2011 and specifically evaluates the impact of the various
mergers and acquisitions that were transacted during those years.
Definition of Terms
Blood Center. The term "blood center" refers to an organization the purpose of which is

to collect, test and distribute blood and blood products to be used for transfusion purposes
in hospitals and other healthcare facilities involved in the provision of patient care.
Sometimes referred to as

~~blood

banks," blood centers may fall under the organizational

umbrella of the American Red Cross, or may be locally organized as a freestanding
community blood center.
Blood Industry. The term "blood industry" refers collectively to all blood centers as

defined above.
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Merger. The term "merger" refers to a transaction in which two organizations combine

most or all of their assets to create a third entity, resulting in a change of control for both
organizations.
Acquisition. The term "acquisition" refers to a transaction in which one organization

gains control of most or all of the assets of a second organization.
Partnership. The term "partnership" refers to a transaction in which two or more

organizations agree to cooperate for mutual benefit; not resulting in a change of control.
Consolidation. The term "consolidation" encompasses mergers, acquisitions, and

partnerships.

CHAPTER II
LITERATURE REVIEW

Healthcare has experienced significant consolidation during the past several decades.
While the main focus has primarily been within the healthcare provider community, there
are examples of consolidation trends in most all sectors of the broader healthcare
industry. A review of the key issues related to healthcare consolidation serves as a basis
upon which the impact of this activity can be evaluated.
Hospital Consolidation

The decade of the 1990s saw a significant upsurge of merger and acquisition activity
among both for-profit and not-far-profit hospitals and health systems. The strength of the
United States economy, coupled with the aggressive growth strategy of for-profit
healthcare companies, created an environment conducive to such activity (Zuckerman,
2009). Coming on the heels of multiple hospital mergers and closures in the 1980s, the
federal government was so concerned about the availability of healthcare services in
certain markets that a study was conducted by the Office of Inspector General of Health
and Human Services. The study concluded that the majority of closures did not lead to
any significant negative effects on individual communities. In fact, in most cases the
resulting mergers addressed key operational issues and the merged hospitals were
stronger finan~ially as a result (Kusserow, 1991).
The not-for-profit sector was characterized by mounting competitive pressures and
merger activity resulting from the need to protect market share, and in some cases,
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counteract the aggressiveness of proprietary hospital chains (Harrison, 2006). From 1995
- 1999, over 750 hospitals underwent a change in ownership or significant re-structuring
of governance and control (Bellandi, 1999; Grauman, Harris, & Martin, 2010). Studies
conducted in the aftermath suggested that most hospital acquisitions in the decade of the
1990s predominantly resulted from poor financial performance on the part of the acquired
organization (Sloan, Osterman, & Conover, 2003). Additionally, organizations that
elected to merge with other entities did so primarily to protect or grow market share
(Harrison, 2006). One study, which analyzed the impact of mergers in two metropolitan
markets, concluded that the primary driving force for the mergers was the hospitals'
concern about being able to compete for managed care contracts (Wicks, Meyer, &
Carlyn, 1998). It furthermore concluded that the mergers were also a means by which
weaker hospitals could stay operational rather than face bankruptcy or foreclosure.
Another study suggested .that health care markets in the 1990s evolved differently
from what was expected initially and that a different consolidation strategy would be
needed as the healthcare industry entered the 21 st century (Olden, Roggenkamp, & Luke,
2002). Conversely, one author stated that the most valuable lessons learned from mergers
of the 1990's were not strategy-related, but related more to the resulting organizational
structure that was adopted after the merger was completed (Seymour, 2009).
During the ten-year period from 2000 - 2009, a total of 597 hospital mergers and
acquisitions were documented, representing 41,850 beds and a financial impact totaling
nearly $74.3 billion (Steever & Swanson, 2010). While these numbers include both forprofit and not-for-profit transactions, they clearly indicate increased activity resulting
primarily from the continued financial pressures in the industry. Interestingly, the
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number of consolidations correlated with other overall economic indicators, with a
downturn in activity in 2008 as the U.S. economy began to struggle (Zuckerman, 2009;
Carlson & Galloro, 2009; Evans & Galloro, 2008).
At the beginning of the 21 st century, some industry experts expressed concern about
the level of merger activity that occurred during the 1990s. One study concluded that
while specific mergers may have indeed strengthened their respective organizations, there
was no documented improvement in service quality or cost savings (Vita & Sacher,
2001). In fact, prices passed on to the consumer actually increased as a result. Another
study that was critical of such strategic alliances suggested that mergers of the future
should focus more on what is good for the patient as opposed to what is good for the
organization (Olden, Roggenkamo, & Luke, 2002). Other studies indicated the need for
more public scrutiny of mergers, especially regarding the formation of dominant local
health systems (Cuellar & Gertler, 2003).
Perhaps the predominant theme of merger activity during the early 2000s was the
need to preserve the bottom line and to better position the organization for the uncertainty
of the future. In many cases, this meant considering the unthinkable: merging with a
cross-town rival (Butcher, 2008). Hospitals that had been fierce competitors began to
seek collaborative efforts to pool resources and develop expanded specialty services.
Access to capital, negotiating strength with payers and acquisition of information
technology took precedence over competitive forces. The goal was to achieve a merged
entity that was stronger financially with a more diverse array of specialty services
(Galloro, 2010).
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By the middle of the decade, it was clear that the merger and acquisition activity was
beginning to change the landscape of hospital competition. Hospital consolidations of the
1990s and early 2000s had raised new issues regarding consumer choice and the limited
options for providers and insurers (Ginsburg, 2005). Questions were raised regarding the
future role of competition and whether it would continue to be an important part of the
United States health system. Other publications criticized hospitals for jumping on the
merger "bandwagon," and suggested that some mergers may have been pursued without
adequate study and analysis (Kaissi & Begun, 2008).
Reasons for Consolidation
Each merger among healthcare providers that occurred in the 1990s and the 2000s
may have had a specific set of objectives based on unique organizational needs; however,
there were several common driving forces and reasons which led to the resulting merger
decisions. One common theme was the desire to preserve or grow market share
(Harrison, 2006). As competitive forces began to escalate in the 1990's, many not-forprofit hospital boards explored alternatives to strengthen their market position and
thereby avoid the need to "sell out" to a for-profit chain, even if it meant joining forces
with their biggest local competitor (Cuellar, 2004). While this strategy caused other
operational and cultural challenges, it was felt to be a preferred alternative that
represented the best interests of the community and preserved the local delivery of
healthcare services (Sloan, Osterman, & Conover, 2003).
Another, perhaps more compelling, driving force was the long term financial
viability of the organization (Zuckerman, 2008). Trustees of independent community'
hospitals that had been faced with eroding margins and reimbursement cuts were forced
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to make difficult decisions that likely meant organizational survival (Gish & Kamholz,
2007). While independence may have been preferable, hospital boards tasked with the
responsibility of determining community need elected to merge with competing hospitals
as the best and perhaps the only feasible strategy for the future (Zuckerman, 2009).
Furthermore, the economies of scale gained through consolidation were shown to have
the potential to lead to a stronger negotiating position with vendors and payers, resulting
in improved access to capital, expense control, clinical service consolidation and pooling
of resources (Minich-Pourshadi, 2010). Conversely, there were times when economic
conditions, regulatory issues, control issues or simply the overriding desire to remain
independent took precedence over the need for consolidation (Carlson, 2010).
Important Pre-Transaction Considerations

As consolidation discussions progress, a number of issues must be addressed before
reaching a final decision. Generally, organizations adopt a formal process to follow to
ensure that all critical aspects of the transaction are thoroughly considered (Choi &
Brommels, 2009). Issues such as financial projections, strategic financial planning,
clinical service delivery, regulatory concerns, size of the merger and community interests
cannot be overlooked in the process (Beckham, 2009; Blecher, 2002). Issues related to
governance and board structure, as well as decisions regarding the selection of
organizational leadership have also been shown to be critical to the long-lasting success
of a merger (Lozon & Vernon, 2002).
Financial Issues. Given that many mergers frequently occur as a result of financial

pressures, it is important that the financial terms make sense for all parties involved, and
that an in-depth study and analysis is accomplished through a detailed due diligence
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process. Particular attention must be given to ensuring that the overall strategy is
supported financially (Zuckerman, 2009). Not surprisingly, some mergers eventually fail,
or do not live up to expectations because financial forecasts have not been accurately
formulated. Others are slow to materialize because of problematic financial projections
(Zuckerman, 2010).
In response to the consolidation activity over the past two decades, the Financial
Accounting Standards Board (F ASB) adopted new accounting guidelines to address notfor-profit mergers and acquisitions (Evans, 2009; Heuer & Travers, 2010). These
standards followed years of debate and demonstrate the increased scrutiny facing not-forprofit organizations in meeting financial disclosure requirements of various governmental
agenCIes.
Regulatory Issues. One of the biggest hurdles to overcome in any potential merger
relates to the scrutiny of the transaction by federal regulatory agencies. Throughout
history, the United States government has influenced market dynamics in the business
sector, dating back to the late 1800s with the Sherman Act, and early 1900s with the
Clayton and Federal Trade Commission Acts. More recently, there have been mandated
notification requirements related to anticipated mergers, and specific merger guidelines
adopted by the Department of Justice (DOJ). A study by Blackstone and Fuhr (1992)
targeted non-profit hospital mergers as an area for concern, and analyzed the anti-trust
and competitive implications of not-for-profit mergers of the 1980s and early 1990s. As
merger activity increased into the 1990s, additional studies were conducted and concerns
were raised about how governlnent regulation and public purchasing affect competitive
markets for hospital services (Hammer & Sage, 2003; Reiffer, 2003). Subsequent studies
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have shown that antitrust merger enforcement standards are not always good predictors of
when a merger might be challenged and have suggested that the anti-trust laws governing
hospital mergers are in need of revision, given the uniqueness of health care markets
(Blesch, 2010). A recent decision reached by the Federal Trade Commission (FTC)
relating to a potential merger received criticism from the industry, further prompting a
call for updated guidelines (Campbell, 2007; Taylor, 2007).
By mid-2009, the FTC and DOl announced that the Horizontal Merger Guidelines
that had been issued in 1992 would be re-examined (Commins, 2009). A number of
industry regulators felt that revisions may be necessary to account for new legal and
economic developments since the last revision of the guidelines. By early 2010, the
proposed guidelines were announced, which intended to place greater emphasis on
healthcare costs and consumer access to healthcare services (Blesch, 2009).
Critical Post-Merger Challenges

Once consolidation is completed, the next maj or challenge relates to implementation.
As such, a number of key issues must be considered to facilitate a successful transaction.
Operational Issues. In many respects, the closure of a merger or acquisition transaction

is the easy part, but putting it into operation presents a new set of challenges. Important
structural issues such as meeting frequency, election of officers, and committee
appointments sometimes remain unclear until late in the process (Mycek, 2008).
Operational issues such as non-duplication of services, consolidation of departments and
programs, reduction in personnel and elimination of executive management must be
addressed immediately following the closure of a merger transaction (Bazzoli, LoSasso,
Arnould, & Shalowitz, 2002). Studies have suggested that failure to address such issues
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in a timely fashion may place the merged entity at a competitive disadvantage as
compared to other similar organizations that choose not to merge (Sinay & Campbell,
2002). While none of these decisions are simple, they are inevitably necessary so as to
realize the full benefit of a merger. If appropriate planning for the merger has been
accomplished as prescribed, many of these decisions should be considered prior to
finalizing the deal (Choi & Brommels, 2009).
The best practices among organizations that have undergone a merger suggest that a
well-defined plan can result in positive post-merger integration (Betka & Mengwasser,
2009). Considering lessons learned in the 1980s and 1990s, it is imperative that
healthcare organizations approach a merger with a non-reactionary management strategy.
In fact, dealing with the difficult issues in a proactive and diligent manner will yield
greater merger benefits. It will also help to establish the new identity of the organization
so that the defined goals and objectives can be accomplished (Betka & Mengwasser,
2009). Another study suggested that a merged organization has a greater opportunity to
receive contribution and participation by key stakeholders because they perceive a ""new
day" in terms of operating philosophy as opposed to "business as usual" (Anderson,
Allred, & Sloan, 2003).
Cultural Issues. While operational issues may often be addressed in an objective

manner, the more rooted issue of organizational culture cannot. Many mergers struggle to
overcome the personality differences of the two organizations and consequently create
additional management challenges (McConnell, 2008). Most organizations spend
significant time and money researching the financial and market position of a potential
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partner, but they fail to consider the cultural differences and how decisions are made on a
daily basis (Lowrey, 2007).
The biggest challenge may be for those in middle management positions who have
broad responsibilities, a large number of employees and whose "ways of doing things"
have suddenly been changed with new executive leadership (McConnell, 2008). Different
styles of communication and the type of information to be communicated may have also
changed dramatically, thus creating an environment of uncertainty (Dooley &
Zimmerman, 2003). The cultural issues become even more complex when the merger
involves secular/religious, community/teaching, and inter-denominational organizations
(Kastor, 2001).
Consumer Issues. One of the major criticisms of hospital consolidation comes from the
general public. The concern revolves around who stands to benefit most: the
organizations involved or the consumer. One argument postulates that mergers are
transacted primarily to increase market power, and issues such as improving service
quality, reducing costs, and improving efficiency are secondary considerations (Ho &
Hamilton, 2000; Cuellar & Gertler, 2005).
Other studies indicate that merged hospitals have effectively controlled growth in
costs, although the cost savings were lower than originally projected (Spang, Bazzoli, &
Arnould, 2001; Conner, Feldman, Dowd, & Radcliff, 1997; Conner, Feldman, & Dowd,
1998). These studies support the overarching argument that economies of scale and
combined resources resulting from a merger can lead to positive outcomes which
ultimately benefit the consumer of healthcare services.

]6

Non-Hospital Consolidation Activity
Consolidation within the healthcare industry has not been exclusively restricted to
hospitals. Significant consolidation has also occurred within other sectors of healthcare
such as medical device companies (Becker, 2005; Levenson, 2011), health maintenance
organizations (Christianson, 1997; Feldman, Wholey, & Christianson, 1996; Given,
1996), dialysis companies (Chartier, Ballesteros, & Neuman, 2005; Sullivan, 2005),
pharmaceutical companies (Taylor &Kleiner, 1998) and physician practices (MinichPourshadi, 2011). The increasing consolidation activity within the blood industry has
been of particular note (Fuchs, 2011).

The Blood Industry
Many of the same issues that led hospitals to consider consolidation as a strategy
have affected the blood industry as well. The need to become more efficient, achieve
economies of scale, improve financial performance and be better positioned to compete
for system contracts has prompted many blood centers to seek new strategic partnerships
and alliances. While many such arrangements have been documented over the past
several decades, a recent upsurge in consolidation activity has been observed. Several
trends unique to the industry have been catalysts for this increased activity (Fuchs, 2011).

Decreased Blood Utilization
As hospitals deal with increased financial and economic pressures, blood centers
become even more vulnerable as a result of their vendor relationship. With the economic
downturn that began in 2008, the delnand for blood has declined nationally, and one
prediction suggests that it will decrease 2-6% annually for the next ten years (Swan,
2010). This is attributable to three distinct forces:
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•

There have been focused efforts questioning- the clinical indications for blood
transfusion, and a growing concern that more blood is transfused than is clinically
necessary (Hannon, 2011).

•

As reimbursements for hospital services have been cut and with anticipated
additional cuts in federally-sponsored programs, hospitals are becoming much more
attuned to the need for reducing the costs associated with blood procurement
(Landro, 2008; Paxton, 2008).

•

With fluctuations in unemployment rates across the United States, many American
citizens have lost their health insurance. Consequently, admissions to hospitals have
declined, as have elective surgical procedures. The demand for blood has followed
the same trend (DeChristopher, 2010). It is speculated that this trend may reverse
somewhat as the population ages and as healthcare reform is implemented.
Unfortunately, as blood utilization in hospitals declines, so does the blood center's

revenue stream since the revenues directly correlate with the volume of sales to hospitals.
Thus, it is imperative that blood centers either look for new sources of revenue or reduce
operating expenses.
Impact on Blood Supply

Historically, blood centers have operated under the assumption that there is a market
for all blood that is collected. This has worked well in the past because the blood that
was collected would either be needed within the local service area, or could be exported
to other blood centers experiencing shortages. With the decline in blood usage, however,
this will not be assured in the future. The industry will focus on the collection of specific
blood types and attempt to match type-specific supply with demand. The impact of
healthcare reform adds an additional degree of uncertainty. There is concern that blood
centers may need to learn to accept financial risk similar to the risk that providers aSSUlne
under a fixed contracting scenario (Swan, 2010). Blood centers will need to learn how to
work with their hospital clients more effectively to better manage blood utilization.
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Group Contracting and Bidding

As a result of recent financial pressures on hospitals and prospects of increasing
pressures, long-standing vendor relationships are being challenged. As hospital systems
have evolved and their centralized management capabilities have become more
sophisticated, the supply chain function has received more attention. Consequently,
health systems now look for every opportunity to use their purchase volume as leverage
in negotiating supplier agreements (Andrews, 2009). In recent years, there have been
several examples of "group bidding" on blood supplier agreements between health
systems and blood centers in the U.S. Some of these re-negotiation efforts have resulted
in strained relationships between hospitals and blood centers that had previously enjoyed
positive and mutually beneficial working relationships (Andrews, 2009). Nevertheless,
the current climate and changing healthcare environment have created an added degree
of friction.
Another important facet of this trend is that as "system contracting" evolves,
individual hospitals within multi -hospital systems may have little or no input into the
contract decision. In the past, most contract negotiations were handled locally with the
hospital CEO in consultation with the hospital blood bank supervisor or director of
transfusion services. As hospital systems take control of the process, negotiations in the
future will likely be with a system supply chain professional that mayor may not be
sensitive to local relationships (Swan, 2010).
Blood Center Consolidation
It is anticipated that the need for additional negotiating "clout" will inevitably lead

to accelerated consolidation within the blood banking industry (Fuchs, 2011). In the past
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several years, a number of independent blood centers have aligned with, merged with, or
been acquired by other blood centers (MacPherson, 2010). Recent examples include
blood centers in Florida (Tracy, 2010; Wright, 2009; MacPherson, 2010), Iowa
(Dreeszen, 2010; Kapler, 2010), Illinois (Kapler, 2010; Allemeier, 2010), California
(Kapler, 2011) and Texas (MacPherson, 2010).
It is expected that consolidations and affiliations between blood centers will

continue in order to achieve economies of scale and generate aggregate cost savings.
Since operating costs will most likely continue to increase due to labor, supplies, and
additional FDA testing requirements, it is important that blood centers explore all
potential options to save money.

The Impact of Healthcare Reform
Since an estimated additional 32 million people will be covered by health insurance,
it is expected that admissions to u.S. hospitals will increase in the short term (Swan,
2010). Conversely, reimbursement for hospital services is scheduled to decrease by $152
million over 10 years, adding another degree of uncertainty (Gelineau, 2010). Revised
reimbursement methodologies that place emphasis on hospital performance, service and
quality will add a new dimension to an already challenging environment. As a result of
anticipated decreased reimbursements, hospitals will implement cost-cutting measures
such as staff reductions and delayed capital investments, as well as a renewed emphasis
on efficiency and process improvement (Evans, 2010). Such initiatives will inevitably
lead to significant operational and strategic repositioning of hospitals.
Industry analysts have forecasted that the trend in healthcare consolidation would
accelerate as healthcare reform is implemented (Galloro, 2010). The extensive
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consolidation of hospitals through mergers and acquisitions has facilitated the formation
of multi-hospital systems and greater emphasis has been placed on the national
importance of their role (Cuellar & Gertler, 2003). In many of these cases, the primary
motivation for system creation has been the ability to use the group purchasing power of
a larger system to achieve better pricing for products and services (Minich-Pourshadi,
2010). Simply put, a large multi-hospital system stands a better chance of negotiating
from a position of strength, whereas an individual hospital left to negotiate alone would
not be able to generate the same degree of leverage (Blecher, 2002).
The enactment of the healthcare reform legislation is anticipated to be an additional
catalyst for even more healthcare consolidation, creating entities that are better able to
leverage the greater purchasing power of a system and apply that power in the negotiation
of vendor and supplier agreements (Galloro, 2010). The combined resources of a larger
organization also allows for the creation of centralized supply chain management
function, with the expressed intent of decreasing the overall expense of product and
service procurement (Barr, 2010). Many locally-created systems have now employed
such measures, which in many ways are modeled after the much larger national hospital
chains.

Implications for the Future
As the first decade of the 2000s neared its end, speculation shifted toward the next
10 years and what lie ahead with respect to mergers and acquisitions. The previous two
decades had seen unparalleled activity in both the for-profit and not-for-profit sectors of
the healthcare industry_ Yet, with the turbulent economic climate and the uncertainty of
the impending healthcare reform legislation as a backdrop, the industry was poised to
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expect another upswing in consolidation activity, guaranteed to bring a new round of
challenges and opportunities (Zuckerman, 2008). The primary driving forces were
predicted to be centered on the consolidation of the insurance industry, tightening capital
markets, decreased reimbursement, workforce shortages, physician practice issues, and
financially stressed providers (Zuckerman, 2008). Some industry experts speculated that
the struggling economy will accelerate the consolidation trend; however, the rate of
transaction closures may be compromised due to tight credit markets (Bakhtiari, 2009).
As of2009, the next wave of consolidation activity is in motion, but with a different
focus than before (Ponte, 2009). Increased understanding of previous mergers and the
need to solicit community support will take on a renewed emphasis (Cutler, 2009).
Market strength and economies of scale will still be key driving forces, as will financial
performance and access to capital (Zuckerman, 2009). Given the reality of what is ahead,
the key question for any independent healthcare organization will be whether or not it is
positioned to remain independent. If not, it is never too soon to start identifying potential
partners. Some experts speculate that the only plausible means for survival may be to
consolidate (Tocknell, 2011). Taking note of what happened in other service industries,
one author has suggested that mergers may even go beyond the boundaries of local
markets, and that nation-wide not-for-profit health systems are a real possibility in the
future (Myers & Lineen, 2009).
With the improving economy in early 2010, consolidation activity began to
accelerate (Galloro, 2011). Fueling this trend were forecasts suggesting that independent
not-for-profit hospitals may not fare well as a result of the healthcare reform legislation.
Healthcare reform will likely drive hospital consolidation since fewer hospitals will be
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able to operate under changes to the insurance and healthcare delivery systems (Evans;
2010). One author has predicted that greater for-profit investment in not-for-profit
hospitals will increase, thereby increasing the level of merger interest among not-forprofit systems (Minich-Pourshadi, 2010).
Perhaps the most compelling reason for increased merger activity concerns access to
capital (Tocknell, 2012). The need to keep pace with clinical technology, the need to
address facility and infrastructure issues of aging physical plants and the mandate to
implement electronic medical records will drive additional hospital consolidation
(Grauman, Harris, & Martin, 2010).

Evaluating the Impact of Consolidation
This paper focuses on the impact of consolidation within the blood industry. While
there has been a great deal of consolidation activity over the past three decades, there are
no published studies that have evaluated the impact of this activity. Therefore, various
methodologies used to evaluate consolidation activity in other sectors of the healthcare
industry were reviewed.
Research studies designed to evaluate the impact of healthcare mergers have taken a
variety of methodological approaches and have arrived at varied conclusions (Bazzoli,
Dynan, Burns, & Yap, 2004). Generally, the primary motives for consolidation have
focused on the need to improve financial performance, achieve operational efficiencies,
improve service quality and gain a competitive advantage (Goldberg, 1999).
Operational efficiencies gained through consolidation include documented benefits
such as cost savings from economies of scale, elimination of duplicative services, pooled
staffing and broader geographic coverage (Conner, Feldman, Dowd, & Radcliff, 1997).
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One study used a time-series analysis approach to compare key pre- and postconsolidation indicators related to scale of operation, operating efficiency and staffing
practices (Alexander, Halpern, & Lee, 1996). It concluded that costs savings that resulted
from consolidation could be documented in certain selected cases. Other studies have
shown that consolidation leads to reduced duplication of services and that pooling of
certain clinical services produced overall financial savings (Bogue, et.al., 1995; Barro &
Cutler, 1997). Still, others showed that hospitals linked via loose strategic alliances may
have gained market power, but have not demonstrated significant operational economies
(Clement, et. aI., 1997; Lynk, 1995). A subsequent study questioned the actual
economies of scale benefits of hospital mergers as they relate to efficiency gains in nonrevenue producing cost centers and suggested that such benefits might also be gained
through nominal pricing adjustments (Dranove, 1998) ..
The importance of market share was the focus of one study of mergers between
competing hospitals operating in the same service area (Brooks & Jones, 1997). This
study concluded that other factors such as financial performance and ownership may
have had greater bearing than market share alone. Another study looked at the evolution
of rural hospital systems to determine the most relevant factors that lead to improved
financial performance (Chan, Feldman, & Manning, 1999). It concluded that certain
economies of scale could be achieved from consolidation as long as an optimum
number of hospitals participated in collective group initiatives. Consolidation
activity that occurred in the 1990s was compared and contrasted with the merger
and acquisition activity of the 1980s (Bazzoli, Manheim, & Waters: 2003). This study
concluded that smaller, financially weak organizations were more likely to join multi-
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hospital-systems in the 1980s, -whereas in the 1990s there was a trend of larger hospitals
joining systems to be better positioned for the future.
Common ownership under a single governance structure has been shown to be an
important indicator of improved financial performance (Bazzoli, Chan, Shortell, &

D' Aunno, 2000). This study concluded that while various models of consolidation may
lead to improved operational benefits, hospitals and health systems that operate under
unified ownership generally have better financial performance than hospitals that are only
linked through some type of contractual arrangement. A subsequent study corroborated
this finding using a unified empirical methodology to assess multi-hospital system
development in comparison with full asset mergers (Dranove & Lindrooth, 2003). The
study concluded that hospital mergers that resulted in consolidated financial reporting as
well as unified operating licenses generated the greatest savings, while only marginal
savings were generated in multi-hospital system consolidation.
Of particular concern is the fact that not all mergers tum out the way they were
originally envisioned. Several studies have evaluated mergers to determine reasons for
their success or failure (Scanlan, 2010). One study analyzed the failed merger of a
Catholic hospital with a non-faith-based community hospital (Eberhart, 2001). It
concluded that the merger failed as a result of three strategic errors: divergent cultures,
negative response from the general public and legal issues related to the charitable
missions of each organization. Similar issues related to culture and mission were
determined to be the downfall of mergers of teaching hospitals (Kastor, 2001).
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Several studies found in the literature have approached the evaluation of healthcare
mergers using similar methodologies. Two studies evaluated hospital mergers and
acquisitions in both the not-for-profit and for-profit sectors to determine if there were
significant financial and operational benefits that could be documented as a result of
consolidation (Alexander, Halpern, & Lee, 1996; Lynch & McCue, 1990). Another study
used a similar approach in the evaluation of mergers among health maintenance
organizations (Weech-Maldonado., 2002). Using a time series analysis to compare preand post-consolidation indicators, this study calculated change scores for key financial
and operating performance measures and then evaluated these scores using appropriate
statistical tools. A companion study identified key strategic factors and evaluated these
factors in association with HMO performance (Weech-Maldonado., 2002). The
approaches used by these studies were determined to be the best methodologies upon
which to model the evaluation of blood center consolidation. Therefore, this paper
employs elements from each of these studies in the collection and analysis of data.

CHAPTER III

METHODOLOGY
Background
Significant research has led to the publication of numerous studies that evaluate and
analyze the impact of consolidation in a variety of healthcare organizations (Bazzoli,
Dynan, Bums, & Yap, 2004). Many of the published studies have focused on the success
or failure of hospital consolidation, but several have also looked at the impact of
consolidation within other health-related organizations such as health maintenance
organizations, dialysis centers, and physician group practices (Bazzoli, Dynan, Burns, &
Yap, 2004). However, it is surprising, given the number of blood center mergers andlor
acquisitions during the past several decades, that there are no published studies that have
empirically analyzed the success or failure of blood center consolidation.
The goal of this study is to prove or disprove the presumption that blood center
consolidation leads to improved financial and operational performance for the resulting
entity_ If blood center consolidation will continue to accelerate as forecasted, the blood
industry would benefit from both a better understanding of past merger andlor acquisition
transactions and an obj ective methodology by which to eva]uate previous consolidation
efforts. An analysis of blood center consolidation in Florida between the years 1991 and
2011 is thereby conducted in hopes of determining the impact of such activity.
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Consolidation as an Organizational Strategy

Like organizations in other industries, most healthcare organizations go through a
strategic planning process that serves to define future goals and objectives. Key
components of this process include assessing both internal and external factors that have
or may potentially have implications for continued success. The external issues quite
often revolve around the various competitive forces that may influence the resulting
strategy.
Porter has defined five competitive forces that playa role in shaping organizational
strategy (Porter, 2008). These five forces include: 1) the threat of the entry of new
competitors; 2) the threat of substitute products or services; 3) the bargaining power of
customers; 4) the bargaining power of suppliers; and, 5) the intensity of competitive
rivalry. When applied to the blood industry, the competitive force model poses some
interesting implications that serve to explain some of the past consolidation activity as
well as provide insight into the future.
Force #1 - Threat of entry of new competitors. As the healthcare industry has changed

in recent years as a result of financial challenges, competition within the blood industry
has intensified. While defined service areas and hospital clients have evolved somewhat
naturally over time, group contracting and bidding for the best prices have altered those
natural boundaries (Fuchs, 2011). Blood centers are being forced to be more competitive
regarding price and service to maintain their current client base, as well as to take
advantage of opportunities to serve new hospital clients when invited to submit a
proposal. The independent community blood center mayor may not be able to bid on
additional business due to geography, size, or other limitations. By collaborating with
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another blood center (or multiple blood centers), the community blood center could
potentially be better prepared to block the entry of undesirable competitors.

Force #2 - Threat of substitute products or services. While it is speculated that
medical research may eventually lead to the development of a substitute for blood and
blood products, it is uncertain how realistic that may be or when such a development may
be available for use in the United States. Nevertheless, blood centers should always
remain cognizant of the fact that the entire industry could be transformed when and if a
blood substitute is made available. In addition, new and changing treatment protocols
such as concerted blood conservation efforts, bloodless surgery and the use of cell saver
technologies may also impact blood utilization in certain clinical applications. This issue
is not addressed within the scope of this study.

Force #3 - Bargaining power of customers. The primary customer base for blood
centers consists of the hospital clients to whom blood and blood products are supplied. Of
notable concern is the fact that the hospital industry is in a major state of transition,
particularly concerning hospital consolidation and system development. One of the main
driving forces of hospital consolidation, as previously noted, is the desire to achieve
advantages based on volume and gain more purchasing leverage with vendors and
suppliers (Goldberg, 1999). When hospitals consolidate through merger or acquisition,
the purchasing power of the combined entity is typically enhanced. As a result, more
pressure is placed on blood centers to remain price competitive so as to retain the
business. Otherwise, the hospital system is likely to look to other suppliers who may not
only serve their needs, but also offer a lower servic·e price. To offset this competitive
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disadvantage, blood centers look to collaboration with other centers in order to achieve
economies of scale and thereby keep product costs low.

Force #4 - Bargaining power of suppliers. Operational costs of blood centers have
become a key focus in recent years as the natural costs of doing business have increased.
This focus has been on both labor and non-labor expenses and many centers have
initiated specific process improvement initiatives to reduce operating costs. Supply chain
management within the blood center has received greater attention mainly due to the
large amount of money that is spent on the supplies required to collect, process, and
distribute blood. To offset the bargaining power exerted by the various suppliers, blood
centers must explore ways to pool or combine purchasing power in order to gain an
added degree of leverage. Sometimes this can be accomplished by participating in one or
more group purchasing organizations (GPOs). However, the GPOs are limited because
there may be other items that are needed that might not be obtained through a GPO
contract. Thus, blood centers pursue collaboration with other centers in order to increase
purchase volume as a means of dealing with the negotiating power of certain vendors and
suppliers.

Force #5 - Intensity of competitive rivalry. Competition among blood centers varies
significantly across the United States. In some areas, there is intense competitive rivalry
between centers serving the same market. This competition may be between independent
blood centers or may be a result of competition between an independent center and one
that is operated by the American Red Cross. In other parts of the U.S., competition is not
as intense because service areas are somewhat defined and have little or no overlap with a
neighboring blood center. This issue is not addressed within the scope of this study.
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Blood Center Consolidation Activity
During the period from 1991-2011, there were over thirty documented mergers
and/or acquisitions involving U.S. blood centers (MacPherson, 2010). This trend
continues today and is expected to accelerate as a result of healthcare reform.
In the state of Florida alone, consolidation activity among blood centers has been
significant. In 1991, there were 20 blood centers in Florida, each operating independently
of each other. By 2011, there were only seven independent blood centers, a direct result
of mergers and acquisitions during that time.
If the forecasts are accurate about continued consolidation within the blood industry,
what lessons can be learned from the consolidation activity that has already occurred?
Has it been successful? Has it accomplished what it was envisioned to accomplish? If so,
what were the documented benefits of consolidation?
Background of Blood Center Activity in Florida
To fully understand the history of the Florida blood industry landscape, a timeline
and description of the pertinent sequence of events was constructed. As a basis of initial
reference, Table 1 provides an alphabetical listing of all 20 independent blood centers
operating in Florida in 1991.
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Table 1
Independent Blood Centers in Florida in 1991

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

•
•

Broward Community Blood Center, Fort Lauderdale
Central Florida Blood Bank, Orlando
Civitan Regional Blood Center, Gainesville
Community Regional Blood Center, St. Petersburg
Edison Regional Blood Center, Ft. Meyers
Holmes Regional Blood Center, Melbourne
Hunter Blood Center, Clearwater
Indian River Blood Bank, Vero Beach
Jacksonville Blood Bank, Jacksonville
Leon County Blood Bank, Tallahassee
Lower West Coast Blood Center, Sarasota
Manatee County Blood Bank, Bradenton
Marion County Blood Bank, Ocala
Naples Community Hospital Blood Bank, Naples
Northwest Florida Blood Center, Pensacola
Putnam County Blood Bank, Palatka
South Florida Blood Services, Palm Beach
Southwest Florida Blood Bank, Tampa
St. Johns County Blood Bank, St. Augustine
R.P. Tew Memorial Blood Center, Lakeland

While some centers merely changed their name for branding purposes, intentional
consolidation activity began in 1992 when Central Florida Blood Bank acquired Marion
County Blood Bank. Since that time, there have been 10 additional mergers or
acquisitions over the subsequent 20-year period. Table 2 provides a tirneline of such
events between 1991 and 2011.
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Table 2
Timeline of Events Involving Blood Centers in Florida, 1991-2011
1991
1992
1992
1993
1993
1994
1996
1997
1997
1998
1999
2000
2001
2002
2004
2006
2007
2008
2008
2008
2009
2009

Broward Community Blood Center changes name to Community Blood
Centers of South Florida
Central Florida Blood Bank acquires Marion County Blood Bank
Civitan Regional Blood Center acquires Putnam County Blood Bank
Leon County Blood Bank changes name to Southeastern Community
Blood Center
Community Regional Blood Center, Hunter Blood Center, and
Southwest Florida Blood Bank merge to form Florida Blood Services
St. John's County Blood Bank changes name to Blood Center of the St.
John's
Edison Regional Blood Center merges with Central Florida Blood Bank
Civitan Regional Blood Center changes name to Lifesouth Community
Blood Centers
Naples Community Hospital Blood Bank changes name to Community
Blood Center
Central Florida Blood Bank acquires Holmes Regional Blood Center
R.P. Tew Memorial Blood Center changes name to BloodNet
Lower West Coast Blood Center changes name to Suncoast
Communities Blood Bank
Jacksonville Blood Bank changes name to Florida Georgia Blood
Alliance
Central Florida Blood Bank changes name to Florida's Blood Centers
Florida Blood Services acquires Manatee County Blood Bank
Florida Georgia Blood Alliance acquires Blood Center of the St. John's
Florida Georgia Blood Alliance changes name to The Blood Alliance
Florida Blood Services acquires Northwest Florida Blood Center
BloodNet acquires Indian River Blood Bank
Southeastern Community Blood Center merges with Florida Blood
Services
Community Blood Centers of South Florida changes name to
Community Blood Centers of Florida
Florida Blood Services acquires BloodNet

As a result of 11 mergers or acquisitions, by the end of 20 11 only seven independent
blood centers remained operational in Florida. All but two had been involved in at least
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one consolidation transaction, and three had been involved in multiple transactions.
Those remaining operational in 2011 area as follows:
•

Community Blood Center, Naples

•

Community Blood Centers of Florida, Miami

•

Florida Blood Services, St. Petersburg

•

Florida's Blood Centers, Orlando

•

Lifesouth Community Blood Centers, Gainesville

•

Suncoast Communities Blood Bank, Sarasota

•

The Blood Alliance, Jacksonville
Study Design

To evaluate blood center consolidation within Florida from 1991 - 2011, a twophased case study design was selected as the most meaningful approach to assess the
impact of this activity. The study design consisted of using qualitative information
gathered through focused interviews, along with subsequent analysis of quantitative data
collected from document review.
Qualitative Study - Focused Interviews

To determine the most pertinent overall issues related to consolidation activity, a
series of focused interviews was conducted with selected individuals who were serving in
an executive capacity within their respective blood centers during the time that the
transaction was finalized. The primary intent of the interview process was to gain the
insight and perspective of the key persons who actually participated in the facilitation of a
merger or acquisition. Information gathered through this process was used to establish the
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strategic rationale behind the decision to merge, acquire, or be acquired, as well as to
augment the subsequent quantitative analysis.
Focused interviews were condu.cted consistent with the general interview guide
technique (Patton, 1990). An interview outline was prepared as a topical guide, including
a checklist to record responses. Specific questions were left unstructured, in no predetermined order and open-ended so as to give the individual being interviewed sufficient
latitude for responses and sharing of information. An example of the interview outline
and checklist is shown in Figure 1.

Figure 1
Focused Interview Outline
1. Why was consolidation strategy considered?

2. What were the key driving forces behind the decision to consolidate?

3. Was more than one option considered? Yes

No_ _

4. Were financial and operational goals established? If so, what were they?

5. Were these goals achieved? Yes

No_ __

6. Would the resulting merger (or acquisition) be considered a success or a
failure? Why?

7. What could or should have been done differently?
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Quantitative-Study - Financial and -Operational Analysis
An analysis of data collected through document review was conducted to determine
the impact that consolidation had on blood center financial and operational performance.
This quantitative analysis provided an empirical means by which the consolidation
activity could be evaluated using pre- and post-consolidation data.

Sources of Data. Because there is no publicly available central repository for blood
center information, the financial and operational data used for analysis were obtained
from two primary sources:
•

Review of information submitted by the respective blood centers to America's Blood
Centers (ABC) in conjunction with the ABC Annual Financial Ratio Survey
(Coenen, 2011).

•

Review of audited Financial Statements and related documents provided by the
respective blood centers.
While it would have been preferable to analyze data from one unified source., it was

felt that the objective use of available data from these two sources provided a consistent
approach to this study.

Measures and Research Hypotheses
Five key financial and operational ratios were selected for use as a means of
establishing uniform measurement criteria. For each individual measure, a corresponding
hypothesis was constructed that was tested based on subsequent analysis of the data that
were gathered.
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A. -Financial-Ratios - Financial performance was measured using three ratios
commonly used to evaluate financial performance in the healthcare industry
(Cleverly and Cameron, 2007; Spielman, 2011). The selected ratios included the
following:

1. Profitability - Defined as Net Income divided by Total Revenue, this ratio
measures the proportion of net income (profit) that is generated from total
revenue.

HO: Consolidation has no impact on the Profitability ratio.
HI: The Profitability ratio will improve as a result of consolidation.
2. Return on Assets - Defined as Net Income divided by Total Assets, this ratio
measures the relationship between income that is generated and total assets.

HO: Consolidation has no impact on the Return on Assets ratio.
H2: The Return on Assets ratio will increase as a result of consolidation.
3. Working Capital to Assets - Defined as Current Assets minus Current
Liabilities divided by Total Assets, this ratio is a financial measure of
liquidity.

HO: Consolidation has no impact on the Working Capital to Assets ratio.
H3: The Working Capital to Assets ratio will increase as a result of
consolidation.
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B. Operational Ratios - Operational performance was measured using two ratios
commonly used as a basis of comparison in the blood industry (Coenen, 2011).
The selected ratios included the following:

4. Labor Costs per Revenue - This ratio, defined as Total Salaries plus
Benefits divided by Total Revenue, measures proportion of labor expense in
relationship to revenue generated.

HO: Consolidation has no impact on the Labor Costs per Revenue ratio.

H4: The Labor Costs per Revenue ratio will decrease as a result of
consolidation
5. Net Income per FTE - This ratio, defined as Net Income divided by the
Total number of Full-Time-Equivalent employees, measures resulting net
income in relationship to the number of staff.

no: Consolidation has no impact on the Net Income per FTE ratio.
H5: The Net Income per FTE ratio will increase as a result of consolidation.
Study Sample
The 11 mergers or acquisitions that occurred in Florida between 1991 and 2011 were
included in the data analysis. Sufficient financial and operational data needed to conduct
the analysis were obtained for the two years before and the two years after each
consolidation transaction. A listing of these transactions and the dates in which they
occurred is provided in Table 3.
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Table 3
Study Sample of Consolidation Transactions
Trans.

Year

Description

1.
2.

1992
1992

3.

1993

4.

1996

5.

1995

6.
7.

2004
2006

S.
9.
10.

200S
200S
200S

11.

2009

Central Florida Blood Bank acquires Marion County Blood Bank
Civitan Regional Blood Center acquires Putnam County Blood
Bank
Community Regional Blood Center, Hunter Blood Center, and
Southwest Florida Blood Bank merge to form Florida Blood
Services
Edison Regional Blood Center merges with Central Florida Blood
Bank
Central Florida Blood Bank acquires Holmes Regional Blood
Center
Florida Blood Services acquires Manatee County Blood Bank
Florida Georgia Blood Alliance acquires Blood Center of the St.
John's
Florida Blood Services acquires Northwest Florida Blood Center
BloodNet acquires Indian River Blood Bank
Southeastern Community Blood Center merges with Florida
Blood Services
Florida Blood Services acquires BloodNet

Blood Center Profile

To further describe the study sample, a profile matrix was constructed showing the
relative size of each blood center and the type of consolidation that occurred. The
definition of blood center size is consistent with the following criteria as adopted by
America~ s

Blood Centers:
Small: 10,000 - 49,999 annual collections
Medium: 50,000 - 99,999 annual collections
Large: 100,000+ annual collections
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While there were 11 consolidation transactions finalized during the study period, the
profile matrix indicates that a total of 23 blood centers were involved during the study
time period. This total accounts for the fact that some centers were involved in multiple
transactions. As such, they were counted separately for each transaction. Additionally,
some centers may have been classified in the small or medium category during one
transaction, but then moved to the medium or large category in subsequent transactions
due to a change in size. The profile matrix is shown in Table 4.

Table 4
Blood Center Profile
Type of
Transaction

Small

Medium

Large

TOTAL

Merged with
another center
Acquired by a
larger center
Acquired a
smaller center
TOTAL

4

2

1

7

6

2

0

8

0

5

3

8

10

9

4
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Transaction Analysis Model
Previous studies have evaluated healthcare mergers and acquisitions by conducting
statistical analyses comparing pre- and post-consolidation data (Lynch and McCue, 1990;
Alexander, Halpern, & Lee, 1996; Weech-Maldonado, 2002). These studies have served
as a basis upon which to empirically assess the impact of consolidation activity using
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financial and operational data collected from available sources. A conceptual model used
to explore these relationships is presented in Figure 2.

Figure 2
Transaction Analysis Model

Blood Center A

t-2

t-l

t

m

m

X
X

Blood Center B

m

m

t+l

m

t+2

m

Consolidated Center

X

t = transition year (year in which consolidation was finalized)
t-l = one year pre-consolidation
t-2 = two years pre-consolidation
t+ 1 = year one post-consolidation
t+2 = year two post-consolidation
m = average measure of selected ratio (Profitability, Return on Assets,
Working Capital to Assets, Labor Costs per Revenue,
Net Income per FTE)
X = data excluded from analysis
Data Analysis
A pre- and post-test study design was used to study the effects of consolidation on
blood center financial and operational performance. All centers that merged with,
acquired or were acquired by another center between the years 1991 and 2011 were
targeted for analysis.
Financial and operational performance was measured for each blood center in each
of the two years immediately before consolidation and the two years following
consolidation. The two-year period was chosen because the resulting impact of
consolidation may not be evident for a period of time after the consolidation is finalized.
The year in which the consolidation was finalized was considered a period of transition,
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therefore the data from that year were excluded-from the analysis. This approach is
consistent with previous research conducted to evaluate other healthcare mergers and
acquisitions (Alexander, Halpern, & Lee, 1996; Lynch and McCue, 1990; WeechMaldonado, 2002).

CHAPTER IV
RESULTS
Qualitative Study

Attempts were made to conduct interviews with 10 individuals who held senior-level
executi ve positions at the targeted blood centers during the time in which the merger or
acquisition was finalized. Of the 10 attempts, seven successful interviews were
completed, two in person and five by telephone.
A written record and checklist of responses was documented for each completed
interview. Responses were summarized to determine common themes as well as areas of
differing opinions. Table 5 summarizes the responses by category.
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Table 5
Interview Responses
1. Why was a consolidation strategy considered?
Response

Frequency

Blood center was financially distressed; needed capital partner

4

To facilitate growth

3

To achieve economies of scale

4

Negotiating leverage with hospitals and vendors

3

2. What were the key driving forces behind the decision to consolidate?
Response

Frequency

Growth in Market Share

6

Achieve economies of Scale

5

Resources needed to explore new or expanded services and products

5

Need to achieve greater operational efficiencies

5

Desire to acquire new clinical and information technologies

5

Resource sharing in core support functions (*)

5

Improved financial performance

5

Positioning for the futureIHealthcare Reform

4

Greater bargaining power with hospital systems

4

Greater bargaining power with vendors

3

Access to capital to address aging physical plant and equipment

3

Declining revenues; increasing costs

3

Competitive threats

3

(*) Examples included Finance, Human Resources, Quality Assurance, Information
Technology, Donor Recruitment, Marketing, and Training)
3. Was more than one option considered? Yes = 4; No = 3
4. Were financial and operational goals established? Yes = 2; No = 5
If so, what were they?
Revenue growth/ Improved profitability
Reduced overhead
Expanded market share
Decreased operational costs
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5. Were these goals achieved?
Comments:
Goals were not achieved immediately; took two or more years to realize .
Costs actually increased first year, then decreased second year and beyond.
Documented savings in labor and supplies expenses.
Savings achieved in overbead.
6. Would the resulting merger (or acquisition) be considered a success or a
failure? Success = 5; Failure = 2
Comments:
Success: It resulted in expanded market share
Operational economies of scale were achieved
Improved financial performance
Strong level of support by both boards
Joint strategic planning was done prior to transaction
Positioned the organization for future sustainability
Failure: There was no defined vision established prior to the transaction
Too much distrust from the very beginning
Unfulfilled promises on the part of the acquiring entity
Unanticipated negative reaction from staff personnel
Negotiations were one-sided
Wish that it had never occurred
Too much middle management resistance
Unrealistic goals were established
Poor execution after the deal was finalized
7. What could or should have been done differently?
Should have engaged an independent consultant to facilitate negotiations
Needed better definition of goals and objectives to be achieved
Should have conducted joint planning prior to finalizing the transaction
Impact of blended organizational cultures was underestimated
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Quantitative Study

Financial and operational data were collected from the sources previously described.
Summary sheets were prepared for each individual blood center and the data necessary to
calculate the ratios under study were recorded corresponding to each of the two preconsolidation (t-2 and t-1) and two post-consolidation (t+ 1 and t+2) years.
Applicable ratios for each blood center were calculated for each of the pre- and postconsolidation years. An average pre-consolidation value for each ratio was then
calculated for each blood center in the study sample. Corresponding calculations were
conducted to determine post-consolidation values. Resulting values for both calculations
were recorded and documented. These values are presented in Appendix A.
Subsequent calculations were conducted so as to determine a Change Score, defined
as the difference between two measured values. Values were determined for each of the
following:
Change Score a -the difference between the post-consolidation average and the pre-

consolidation average (Post Avg - Pre Avg).
Change Score b - the difference between year one post-consolidation and the pre-

consolidation average [(t+ 1) - Pre Avg].
Change Score c - the difference between year two post-consolidation and the pre-

consolidation average [(t+2) - Pre Avg].
Average values of Change Scores for the study sample were calculated in order to
arrive at an aggregate mean Change Score for each ratio under study. The value of the
mean Change Scores were then used to determine whether there was an observed positive
or negative change in each of the five ratios. Conclusions regarding these changes were
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determined based ~on this initial data analysis. Since the sample size included 100% of the
study population, additional tests for significance were deemed to be unnecessary.
For each of the five hypotheses defined earlier, there were three sub-hypotheses
constructed to evaluate the three Change Scores (a, b, and c) previously described. Table
6 summarizes the resulting values.

Table 6
Quantitative Analysis Summary
Ratio
Profitability
Hla
Hlb
HIe
Return on
Assets
H2a
H2b
H2c
Working
Capital to
Assets
H3a
H3b
H3c
Labor Costs
per Revenue
H4a
H4b
H4c
Net Income
perFTE
H5a
H5b
H5c

Mean

Std. Dev

N

0.0066
0.0017
0.0114

0.0302
0.0261
0.0349

11
11
11

0.0084
0.0012
0.0155

0.0316
0.0348
0.0301

11
11
11

-0.0088
-0.0173
-0.0003

0.0570
0.0532
0.0613

11
11
11

-0.0016
0.0005
-0.0033

0.0258
0.0218
0.0315

11
11
11

33
-232.91
298.91

3105.22
2925.18
3339.1

11
11
11
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Hypothesis 1: Profitability
Hypothesis 1 states that the Profitability ratio will improve as a result of
consolidation. To test this hypothesis, three sub-hypotheses were defined as follows:
Hla: The average profitability ratio for the combined two years post-consolidation

will be better than the average profitability ratio for the combined two years preconsolidation.
The positive value of the mean (0.0066) indicates that profitability did improve when
the average of the two pre-consolidation years was compared to the average of the two
post-consolidation years.
Hlb: The average profitability ratio for year one post-consolidation will be better

than the average profitability ratio for the combined two years pre-consolidation.
The positive value of the mean (0.0017) indicates that profitability did improve when
the average of the two pre-consolidation years was compared to year one postconsolidation.
Hlc: The average profitability ratio for year two post-consolidation will be better

than the average profitability ratio for the combined two years pre-consolidation.
The positive value of the mean (0.0114) indicates that profitability did improve when
the average of the two pre-consolidation years was compared to year two postconsolidation.
Hypothesis 2: Return on Assets
Hypothesi s 2 states that the Return on Assets will increase as a result of
consolidation. To test this hypothesis, three sub-hypotheses were defined as follows:
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H2a: The average Return on Assets ratio for the combined two years postconsolidation will be higher than the average Return on Assets ratio for the combined two
years pre-consolidation.
The positive value of the mean (0.0084) indicates that Return on Assets did improve
when the average of the two pre-consolidation years was compared with the average of
the two post-consolidation years.

H2b: The average Return on Assets ratio for year one post-consolidation will be
higher than the average of the combined two years pre-consolidation.
The positive value of the mean (0.0012) indicates that Return on Assets did improve
when the average of the two pre-consolidation years was compared with year one postconsolidation.

H2c: The average Return on Assets ratio for year two post-consolidation will be
higher than the average of the combined two years pre-consolidation.
The positive value of the mean (0.0155) indicates that Return on Assets did improve
when the average of the two pre-consolidation years was compared with year two postconsolidation.

Hypothesis 3: Working Capital to Assets
Hypothesis 3 states that the Working Capital to Assets ratio will increase as a result
of consolidation. To test this hypothesis, three sub-hypotheses were defined as follows:

H3a: The average Working Capital to Assets ratio for the combined two years postconsolidation will be better than the average Working Capital to Assets ratio for the
combined two years pre-consolidation.

49

The negative value of the mean (-0.0088) indicates that Working Capital to Assets
actually declined when the average of the two post-consolidation years was compared
with the two pre-consolidation years.

H3b: The average Working Capital to Assets ratio for year one post-consolidation
will be better than the average Working Capital to Assets ratio for the combined two
years pre-consolidation.
The negative value of the mean (-0.0173) indicates that the Working Capital to
Assets ratio actually declined when the average of the two pre-consolidation years was
compared to year one post-consolidation.

H3c: The average Working Capital to Assets ratio for year two post-consolidation
will be better than the average Working Capital to Assets ratio for the combined two
years pre-consolidation.
The negative value of the mean (-0.0003) indicates that the Working Capital to
Assets ratio actually declined when the average of the two pre-consolidation years was
compared to year two post-consolidation.

Hypothesis 4: Labor Costs to Revenue
Hypothesis 4 states that the Labor Costs per Revenue ratio will decrease as a result of
consolidation. To test this hypothesis, three sub-hypotheses were constructed as follows:

H4a: The average Labor Costs to Revenue ratio for the combined two years postconsolidation will be lower than the average Labor Costs per Revenue for the combined
two years pre-consolidation
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The negative value of the mean (-0.0016) indicates that the Labor Costs per Revenue
ratio was reduced when the average of the two pre-consolidation years was compared
with the average of the two post-consolidation years.
H4b: The average Labor Costs per Revenue ratio for year one post-consolidation

will be lower than the average Labor Costs per Revenue for the combined two years preconsolidation.
The positive value of the mean (0.0005) indicates that the Labor Costs per Revenue
actually increased when the average of the two pre-consolidation years was compared
with year one post-consolidation.
H4c: The average Labor costs per Revenue ratio for year two post-consolidation will

be lower than the average Labor Costs per Revenue for the combined two years precanso lidation.
The negative value of the mean (-0.0033) indicates that the Labor Costs per Revenue
decreased when the average of the two pre-consolidation years was compared with year
two post -consolidation.
Hypothesis 5: Net Income per FTE

Hypothesis 5 states that the Net Income per FTE ratio will increase as a result of
consolidation. To test this hypothesis, three sub-hypotheses were constructed as follows:
H5a: The average Net Income per FTE ratio for the combined two years post-

consolidation will be higher than the average Net Income per FTE for the combined two
years pre-consolidation.
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The positive value of the mean (33) indicates that Net Income per FTE increased
when the average of the two pre-consolidation years was compared with the average of
the two post-consolidation years.
H5b: The average Net Income per FTE ratio for year one post-consolidation will be

higher than the average Net Income per FTE for the combined two years preconsolidation.
The negative value of the mean (-232.91) indicates that Net Income per FTE actually
decreased when the average of the two pre-consolidation years was compared with the
average of year one post-consolidation.
H5c: The average Net Income per FTE ratio for year two post-consolidation will be

higher than the average Net Income per FTE for the combined two years preconsolidation.
The positive value of the mean (298.91) indicates that the average net Income per
FTE increased when the average of the two pre-consolidation years was compared with
the average of year two post-consolidation.

CHAPTER V
DISCUSSION
Introduction

The inception of this study grew out of the need to gain additional insight into the
impact of blood center consolidation. While blood center mergers and acquisitions in the

u.s. have been occurring for over 25 years, historical transactional data is not readily
available so as to conduct an in-depth analysis. Many of these consolidation transactions
were never studied or evaluated in a formal manner. Furthermore, data on the impact of
consolidation and what was accomplished through consolidation does not exist, at least
not in published form. In fact, access to data necessary to conduct any type of meaningful
study is difficult to obtain and can only be obtained upon request and permission granted
by individual blood centers. Nevertheless, since the trend of consolidation continues to
accelerate, the impact of this activity certainly merits research and study.
While it would have been preferred to conduct this evaluation using a study sample
of all blood centers in the United States that have been involved in consolidation activity,
it was not practical in terms of data availability. Therefore, a manageable study sample of
blood centers in Florida was chosen based on the following reasons:
1. Florida is one of the states where mergers and acquisitions have been quite active,
at least in the last 20 years. Hence, the consolidation activity in Florida provided a
valuable opportunity for a case study.
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2. While access to data posed certain challenges, there was a sincere interest on the
part of several key individuals in leadership positions at blood centers in Florida
to provide the data and information necessary to conduct this study. Their support
in this endeavor is certainly appreciated.
3. Consolidation activity among U.S. blood centers is certain to continue, especially
in the state of Florida.
While an obvious limitation to this study is the relatively small sample size of 11
transactions, the study serves to provide qualitative as well as analytic insight into past
consolidation activity. In this regard, it serves as a basis upon which future consolidation
activity might be evaluated so as to forecast the impact of consolidation efforts.

Qualitative Findings
Findings as a result of the focused interview process appear to be consistent with
Porter's competitive force model described earlier. Porter's Force #1 suggests that
organizational strategy is often determined based on the threat of new competitors in the
marketplace. Focused interview results clearly indicate that one of the key driving forces
behind the decision leading to blood center consolidation was the need to become more
efficient operationally to keep costs from escalating. This, in turn, would allow pricing to
remain competitive to maintain and grow market share.
Another key driving force evident from the interviews was the blood center's need to
be positioned to bid on hospital system contracts. The trend of system contracting has
forced blood centers to be more price competitive and cover a wider geographical service
area. Collaboration with other blood centers can serve to address both issues.
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Similarly, interview results indicated a strong desire to gain additional bargaining
power with hospitals (i.e., customers) when negotiating service contracts, as defined by
Porter's Force,#3. By consolidating with other blood centers, smaller blood centers are
able to achieve a level of bargaining power and market growth that they could not have
achieved alone. Given the consolidation that is occurring among hospitals, blood centers
are likely to respond to market pressures by consolidating with other centers.
The need for improved financial performance and the achievement of economies of
scale was clearly evident in interview responses. This is consistent with Porter's Force #4
which defines the strategic need to maintain a strong negotiating position with suppliers.
As evidenced by the responses, blood centers have placed greater focus on both labor and
non-labor expenses in an effort to become more efficient. By collaborating with other
centers, overall purchase volume increases and thereby achieves greater leverage in
negotiations with suppliers and vendors.
Quantitative Findings

A limiting aspect of the study design was that insufficient data were available to
amass a sufficient sample size so that the results could be generalized to describe the
broader blood industry. Consequently, any inferences drawn from the resulting
calculations could only be made as they relate to the II-transaction sample size.
Profitability. The findings suggest that profitability indeed improved following

consolidation. Based on the data that were analyzed, the average profitability ratio
increased by 0.0066 when the two post-consolidation years were compared to the two
pre.:.consolidation years. Most of the improvement was realized in year two post-
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consolidation (0.0114), although some improvement was also realized in year one postconsolidation (0.0017).
These findings serve to support the responses that were identified through the
focused interview process. As previously noted, there was sufficient evidence in the
interview process to suggest that improved financial performance was a desired outcome
of consolidation. The respondents, who acknowledged that these goals had been
achieved, also stated that the results were not immediately evident in year one postconsolidation, but that it generally took about two years before the desired results were
realized.
Return on Assets. The average pre- and post-consolidation comparisons for Return on

Assets increased by 0.0084, indicating that the Return on Assets ratio was greater postconsolidation. These findings suggest that the consolidated organizations made better use
of their assets in generating income, as compared to the individual organizations
operating as separate entities. Much like the Profitability ratio, most of the improvement
was realized in year two post-consolidation (0.0155), although there was also slight
improvement in year one post-consolation (0.0012).
These findings also serve to support the responses that were provided as part of the
focused interview process. Specific goals that were identified such as growth in revenue,
reduced overhead, economies of scale and decreased operational costs all factor into an
improved Return on Assets ratio for the combined entity.
Working Capital to Assets. A somewhat surprising finding was that the Working

Capital to Assets ratio actually declined as a result of consolidation. When comparisons
were made between the two pre-consolidation years and the two post-consolidation years,
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the average Working Capital to Assets ratio decreased by 0.0088. This ,vas also the case
for each of the two post-consolidation years (-0.0173 in year one and -0.0003 in year
two). The explanation for this decrease could be attributed to a number of factors such as
a decline in cash, an increase in short term liabilities, or a disproportionate increase in
fixed assets resulting from the transaction.
These findings also run somewhat counter to the focused interview responses. It was
the general feeling among respondents that the overall financial structure of the blended
organization would be strengthened. While Profitability and Return on Assets showed
slight improvement., the Working Capital necessary to achieve operational goals may
have actually been compromised, perhaps due to the use of cash to finalize the
transaction. The resulting consolidation effort may have also led to more fixed assets
such as property, plant and equipment as opposed to liquid assets.

Labor Costs per Revenue. One of the intended benefits of consolidation is to achieve
operational efficiencies in the use of staff. Comparisons of the Labor Costs per Revenue
ratio indicated that the average Labor Costs per Revenue were lower (-0.0016) in the two
post-consolidation years. The ratio did, however, show a slight increase in year one postconsolidation (0.0005), with greater improvement, as expected, realized in year two postconsolidation (-0.0033).
These findings were consistent with the focused interview responses which indicated
that most operational savings were realized at least two years post-consolidation. The
respondents indicated that overall costs increased during the first year post-consolidation,
but that the real savings occurred in year two and beyond.
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A significant limitation to the use of this" ratio was identified during this study. The
calculation of labor costs did not consider the fact that some blood centers may outsource
certain key functions such as telephone recruiting and laboratory testing, as well as
administrative and support functions such as payroll, custodial services and facility
maintenance. The outsourcing of such areas would certainly skew the total labor costs
since these costs would show up as general expense items rather than lahor expense.
Further study would be necessary to obtain this level of detailed information.
Net Income per FTE. Study findings suggest that the average Net Income per FTE ratio
increased when compared between the two pre-consolidation and two post-consolidation
years (33). Most of this increase was realized in year two post-consolidation (298.91),
while there was actually a decrease in year one post-consolidation (-232.91).
These findings were also consistent with the focused interview responses which
acknowledged that overall financial and operational improvements were not evident until
at least two years post-consolidation. The operational efficiencies that were desired as a
result of consolidation were eventually realized; however, several years of operations
were necessary to document savings.
Much like the Labor Costs per Revenue ratio previously described, the Net income
per FIE ratio does not consider the outsourcing of key operational functions. Again, this
would be an area for further study.
Limitations
There are several limitations to this study that may merit additional research. First,
the data used in the analysis, while believed to be accurate, were gathered from various
sources rather than one central repository of information. Since there is no centralized
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data base from which to access blood center information, some of the data was retrieved
manually from individual blood center reports. Second, since the study relied on limited
primary and secondary data, the full intent of the consolidation activity may not have
been ascertained from the study sample. Third, the study is limited to consolidation
activity in Florida. While many of the same issues have affected blood centers in other
states and other regions of the U.S., the results of this study cannot be assumed to apply
universally throughout the industry. Fourth, the analysis is limited to a few selected
financial and operational measures. Future studies could expand upon these measures to
gain additional insight. Fifth, the impact of consolidation during the study period may not
be assumed to be the same in the future, given the rapidly changing healthcare
environment and changes in industry and individual market conditions. Additional study
is required to assess the impact of more current mergers and acquisitions which may be
prompted by a different set of driving forces.
Conclusions

Despite the limitations of this study, the findings suggest that there were several
inherent benefits of blood center consolidation in Florida between the years of 1991 and
2011. Based on the qualitative findings of focused interviews as well as quantitative
analysis of defined financial and operational measures, conclusions could be drawn that
the resulting impact of consolidation was positive, at least for blood centers. Additional
study would be required in order to determine the specific impact on the hospital
customers and the volunteer donor base.
Due to the nature of the focused interview process, responses to the set of questions
varied greatly. The feedback from this aspect of the study primarily served to gain
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-general insight into the reasons and key driving forces behind consolidation. It was
obvious that those who were interviewed primarily based their individual impressions of
the resulting consolidation transaction on their own personal interests and perspectives.
Positive responses were more likely to be articulated by those who survived the transition
and retained a responsible position with the resulting entity. Conversely, more negative
responses were likely to be voiced by those whose resulting position may have been
jeopardized as a result of the consolidation. Additional study is needed to structure a
more objective survey methodology.
The quantitative phase of the study likewise provided a general impression of how
consolidation impacted financial and operational measures. The analysis was limited due
to a small sample size; therefore the results cannot be generalized to a larger population
of blood centers beyond this limited study sample. However, based solely on pre- and
post-consolidation comparative data, general conclusions could suggest that the 11
transactions in Florida during the targeted time resulted in improved Profitability, Return
on Assets, Labor Costs per Revenue, and Net Income per FTE. Conversely, the Working
Capital to Assets ratio actually decreased during the two years post-consolidation.
Recommendations for Further .Research

This study can serve as an empirical model to be followed in conducting future
research of consolidation activity among blood centers. As previously stated,
consolidation activity will most certainly continue into the immediate future. As more
consolidation occurs, and as more data are made available, additional research will be
needed to determine long term impact.
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The primary limitation is access to data. A more meaningful study would be one in
which data were available for all V. S blood centers that have merged with, acquired or
been acquired by other blood centers. A study of this proportion would create a sample
size sufficient to draw more definitive conclusions regarding the impact of consolidation.
Vntil these data are available, however, a limited study may be one way in which to
establish a template for further research.
Post Note

Shortly after this study was initiated in mid-20 11, the three largest blood centers in
Florida (Florida Blood Services, Florida's Blood Centers, and Community Blood Centers
of Florida) announced their intentions to merge. This transaction was eventually finalized
in January, 2012 creating a new entity by the name of One Blood. As a result of this
merger, there are now only five remaining independent blood centers operating in
Florida.
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APPENDIX A:
CHANGE SCORE CALUCATIONS AND SUMMARY STATISTICS FOR
PRE-AND POST -CONSOLIDATION RATIO ANALYSIS

H1

Trans#

t-2

t

t-l

t+1

Profita biIity

Pre Avg

t+2

Post Avg

Hla

Hlb

HIe

Post
Avg-

(t+l) -

(t+2) -

Pre Avg

Pre Avg

Pre Avg

1

0.051

0.05

0.051

0.063

0.0505

0.057

0.0065

0.0005

0.0125

2

0.059

0.05

0.057

0.061

0.0545

0.059

0.0045

0.0025

0.0065

3

-0.006

0.049

-0.012

-0.004

-0.0275

-0.008

-0.0295

-0.0335

-0.0255

4

0.051

0.052

0.076

0.085

0.0515

0.0805

0.029

0.0245

0.0335

5

0.042

0.035

0.059

0.067

0.0385

0.063

0.0245

0.0205

0.0285

6

0.063

0.024

0.073

0.078

0.0435

0.0755

0.032

0.0295

0.0345

7

0.06

0.059

0.051

0.056

0.0595

0.0535

-0.006

-0.0085

-0.0035

8

0.056

0.05

0.045

0.053

0.053

0.049

-0.004

-0.008

9

0.025

0.022

-0.009

-0.013

0.0235

-0.011

-0.0345

-0.0325

-0.0365

10

0.07

0.065

0.045

0.053

0.0675

0.049

-0.0185

-0.0225

-0.0145

11

0.045

-0.031

0.053

0.097

0.007

0.075

0.068

0.046

0.09

Mean

0.0066

0.0017

0.0114

Std Dev

0.0302

0.0261

0.0349

11

11

11

0

Summary Statistics:

N
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Return on Assets
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t-2

t-l

t

t+l
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Avg

t+2
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Avg

H2a

H2b

H2c

Post
Avg-

(t+l) -

(t+2) -

PreAvg

Pre Avg

Pre Avg

1

0.054

0.053

0.068

0.072

0.0535

0.07

0.0165

0.0145

0.0185

2

0.068

0.069

0.066

0.081

0.0685

0.0735

0.005

-0.0025

0.0125

3

0.014

0.045

-0.018

-0.012

0.0295

-0.015

-0.0445

-0.0475

-0.0415

4

0.06

0.064

0.072

0.08

0.062

0.076

0.014

0.01

0.018

5

0.06

0.066

0.08

0.088

0.063

0.044

0.021

0.017

0.025

6

0.041

0.04

0.088

0.092

0.0405

0.09

0.0495

0.0475

0.0515

7

0.005

0.026

0.022

0.03

0.0155

0.026

0.0105

0.0065

0.0145

8

0.065

0.064

0.06

0.071

0.0645

0.0655

0.001

-0.0045

0.0065

9

0.049

0.046

-0.021

0.035

0.0475

0.0045

-0.0405

-0.0685

-0.0125

10

0.065

0.068

0.06

0.071

0.0665

0.0655

-0.001

-0.0065

0.0045

11

0.065

-0.017

0.071

0.098

0.024

0.0845

0.0605

0.047

0.074

0.0084

0.0012

0.0156

0.0316
11

0.0348
11

0.0301
11

Summary Statistics:
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Std
Dev
N
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H3
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t-2

t-l

t

t+l

Working Capital to Assets

t+2

Pre
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Avg

Avg

H3a
Post
Avg-

H3b

H3c

(t+l) -

(t+2) -

Pre Avg

Pre Avg

Pre Avg

1

0.312

0.325

0.344

0.369

0.3185

0.3565

0.038

0.0255

0.0505

2

0.39

0.432

0.318

0.329

0.411

0.3235

-0.0875

-0.093

-0.082

3

0.425

0.41

0.316

0.304

0.4175

0.31

-0.1075

-0.1015

-0.1135

4

0.335

0.373

0.329

0.353

0.354

0.341

-0.013

-0.025

-0.001

5

0.34

0.335

0.315

0.331

0.3375

0.323

-0.0145

-0.0225

-0.0065

6

0.316

0.332

0.418

0.446

0.324

0.432

0.108

0.094

0.122

7

0.357

0.372

0.371

0.385

0.3645

0.378

0.0135

0.0065

0.0205

8

0.372

0.391

0.347

0.385

0.3815

0.366

-0.0155

-0.0345

0.0035

9

0.311

0.353

0.331

0.341

0.332

0.336

0.004

-0.001

0.009

10

0.365

0.368

0.347

0.362

0.3665

0.3545

-0.012

-0.0195

-0.0045

11

0.443

0.319

0.362

0.38

0.381

0.371

-0.01

-0.019

-0.001

-0.0088

-0.0173

-0.0003

0.057
11

0.0532
11

0.0613
11

Summary Statistics:
Mean
Std

Dev
N
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H4

Trans#

t-2

t-l

t

t+l

l~bor

Costs per Revenue

t+2

H4a
Post
Avg-

H4b

H4c

(t+l) -

(t+2) -

Pre Avg

Post Avg

Pre Avg

Pre Avg

Pre Avg

1

0.486

0.477

0.476

0.482

0.4815

0.479

-0.0025

-0.0055

0.0005

2

0.518

0.499

0.522

0.499

0.5085

0.5105

0.002

0.0135

-0.0095

3

0.523

0.517

0.516

0.519

0.52

0.5175

-0.0025

-0.004

-0.001

4

0.456

0.465

0.453

0.436

0.4605

0.4445

-0.016

-0.0075

-0.0245

5

0.519

0.541

0.487

0.479

0.53

0.483

-0.047

-0.043

-0.051

6

0.462

0.409

0.449

0.441

0.4355

0.445

0.0095

0.0135

0.0055

7

0.521

0.511

0.515

0.517

0.5155

0.516

0

-0.001

0.001

8

0.42

0.392

0.387

0.379

0.406

0.383

-0.023

-0.019

-0.027

9

0.338

0.387

0.353

0.339

0.3625

0.346

-0.0165

-0.0095

-0.0235

10

0.364

0.348

0.387

0.379

0.356

0.383

0.027

0.031

0.023

11

0.341

0.353

0.379

0.417

0.347

0.398

0.051

0.032

0.07

-0.0016
0.0258
11

0.0005
0.0218
11

-0.0033
0.0315
11

Summary Statistics:
Mean
Std Dev
N
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Net Income per
H5

Trans#

t-2

t-1

t

t+l

FTE

t+2

Pre Avg

Post
Avg

HSa
Post
Avg-

H5b

HSc

(t+1) -

(t+2) -

Pre Avg

Pre Avg

Pre Avg

1

3891

3993

4951

5003

3942

4977

1035

1009

1061

2

3175

3309

3548

3672

3242

3610

368

306

430

3

780

1036

-921

-721

908

-821

-1729

-1829

-1629

4

4298

4264

4880

5388

4281

2459

853

599

1107

5

3858

3797

4057

4465

3827.5

4261

433.5

229.5

637.5

6

4537

2636

5073

5465

3586.5

2819

1682.5

1486.5

1878.5

7

4829

4787

2847

2865

4808

2856

-1952

-1961

-1943

8

6121

6184

7204

7412

6152.5

3958

1155.5

1051.5

1259.5

9

6156

6171

-1758

-1280

6163.5

-1519

-7682.5

-7921.5

-7443.5

10

5927

5688

7204

7412

5807.5

7308

1500.5

1396.5

1604.5

11

5450

-231

5681

8935

2609.5

7308

4698.5

3071.5

6325.5

33
3105.22
11

-232.91
2925.18

298.91
3339.1
11

Summary Statistics:
Mean
Std Dev

N

11

